INIS
patients
100%
eyes
77%
indonesia
41%
surgery
30%
reviews
30%
management
29%
diseases
28%
hospitals
22%
inflammation
22%
comparative evaluations
20%
therapy
20%
risks
20%
levels
18%
vision
18%
tuberculosis
16%
lasers
15%
evaluation
13%
children
13%
cataracts
12%
leprosy
12%
injection
11%
data
11%
rabbits
10%
tumors
10%
trauma
10%
control
9%
injuries
9%
surveys
9%
optics
9%
cornea
8%
ophthalmology
8%
nerves
8%
covid-19
8%
closures
8%
populations
7%
grafts
7%
screening
7%
values
7%
lenses
7%
ulcers
7%
income
7%
pediatrics
6%
hiv
6%
doses
6%
membranes
6%
safety
6%
thickness
6%
sensitivity
6%
genes
6%
symptoms
6%
infants
6%
biological markers
6%
people
5%
implants
5%
clinical trials
5%
edema
5%
viruses
5%
males
5%
retina
5%
correlations
5%
assessments
5%
interferon
5%
hemorrhage
5%
Keyphrases
Indonesia
45%
Visual Acuity
21%
Uveitis
18%
Intraocular Pressure
13%
Jakarta
13%
Meta-analysis
13%
Systematic Meta-analysis
12%
Retinoblastoma
11%
Left Eye
11%
Leprosy
10%
Blindness
9%
Vitrectomy
9%
Ocular Tuberculosis
8%
Cataract
8%
Pada
7%
Tuberculosis
7%
Dry Eye
7%
Risk Factors
7%
Cornea
7%
Visual Impairment
6%
Cytomegalovirus
6%
Clinical Characteristics
6%
COVID-19
6%
Proliferative Diabetic Retinopathy
6%
Anterior Uveitis
6%
Glaucoma
6%
Indonesian
6%
Best-corrected Visual Acuity
6%
Ophthalmologist
5%
Tumor
5%
Glaucoma Patients
5%
Causes of Blindness
5%
Intravitreal Bevacizumab
5%
Inflammation
5%
Amniotic Membrane Transplantation
5%
Computed Tomography
5%
Cataract Surgery
5%
Diabetic Retinopathy
5%
Right Eye
5%
Proptosis
5%
Corneal Ulcer
5%
Visual Outcome
5%
Leprosy Patients
5%
Clinical Manifestations
5%
Endophthalmitis
5%
Eyelid
5%
Medicine and Dentistry
Visual Acuity
22%
Systematic Review
16%
Uveitis
15%
Intraocular Pressure
14%
Visual Impairment
14%
Meta-Analysis
13%
Glaucoma
11%
Diseases
9%
Eye Injury
9%
Neoplasm
9%
Vitrectomy
9%
Eye Disease
8%
Ocular Tuberculosis
8%
Retinoblastoma
8%
Cataract
8%
Infection
7%
COVID-19
7%
Dry Eye
7%
Retinal Detachment
7%
Cataract Surgery
6%
Prevalence
6%
Pediatrics
6%
Ophthalmology
5%
Vitreous
5%
Diabetes Mellitus
5%
Vasculotropin
5%
Bevacizumab
5%
Injury
5%
Amnion
5%
Cross Sectional Study
5%
Human Immunodeficiency Virus
5%